Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia

Published:2006-10 Issue:8 Volume:95 Page:1108-1113
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Scardocci A,Guidi F,D'Alo' F,Gumiero D,Fabiani E,DiRuscio A,Martini M,Larocca L M,Zollino M,Hohaus S,Leone G,Voso M T

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6603392.pdf

Reference19 articles.

1. Bianco T, Chenevix-Trench G, Walsh DC, Cooper JE, Dobrovic A (2000) Tumour-specific distribution of BRCA1 promoter region methylation supports a pathogenetic role in breast and ovarian cancer. Carcinogenesis 21: 147–151

2. Blackshear PE, Goldsworthy SM, Foley JF, McAllister KA, Bennett LM, Collins NK, Bunch DO, Brown P, Wiseman RW, Davis BJ (1998) Brca1 and Brca2 expression patterns in mitotic and meiotic cells of mice. Oncogene 16: 61–68

3. Catteau A, Morris JR (2002) BRCA1 methylation: a significant role in tumour development? Semin Cancer Biol 12: 359–371

4. Christiansen DH, Andersen MK, Pedersen-Bjergaard J (2003) Methylation of p15INK4B is common, is associated with deletion of genes on chromosome arm 7q and predicts a poor prognosis in therapy-related myelodysplasia and acute myeloid leukemia. Leukemia 17: 1813–1819

5. Costello JF, Fruhwald MC, Smiraglia DJ, Rush LJ, Robertson GP, Gao X, Wright FA, Feramisco JD, Peltomaki P, Lang JC, Schuller DE, Yu L, Bloomfield CD, Caligiuri MA, Yates A, Nishikawa R, Su Huang H, Petrelli NJ, Zhang X, O'Dorisio MS, Held WA, Cavenee WK, Plass C (2000) Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet 24: 132–138

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methylation synthetic lethality: Exploiting selective drug targets for cancer therapy;Cancer Letters;2024-08

2. High expression of BCAT1 sensitizes AML cells to PARP inhibitor by suppressing DNA damage response;Journal of Molecular Medicine;2024-02-10

3. WITHDRAWN: MiR-3913-5p is a novel key regulator of differentiation arrest in acute myeloid leukemia;Gene Reports;2024-01

4. BRCA1 and TP53 codeficiency causes a PARP inhibitor–sensitive erythroproliferative neoplasm;JCI Insight;2022-12-22

5. Molecular-Targeted Therapy for Tumor-Agnostic Mutations in Acute Myeloid Leukemia;Biomedicines;2022-11-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3